Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Pharmacy ; (12): 1260-1265, 2020.
Artigo em Chinês | WPRIM | ID: wpr-821617

RESUMO

OBJECTIVE:To syst ematically evaluate the effectiveness and safety of ticagrelor versus clopidogrel in the treatment of acute coronary syndrome (ACS)patients in East Asia ,and to provide evidence-based references for clinical drug use. METHODS:Retrieved from Cochrane Library ,PubMed,Embase,CNKI,Wanfang database ,etc.,randomized controlled trials (RCTs)about ticagrelor (trial group )versus clopidogrel (control group )in the treatment of ACS patients in east Asia were collected. After literature screening and data extraction ,the quality of included literatures was evaluated by using biasrisk evaluation tool recommended by Co chrane system evaluation manual 5.1.0,and Meta-analysis was performed by using Rev Man 5.3 statistical software. RESULTS :A total of 5 RCTs were included ,with a total of 4 511 cases. Meta-analysis showed that the incidence of major adverse cardiovascular events [OR =0.85,95%CI(0.68,1.04),P=0.12],the incidence of death from cardiovascular causes [OR =0.76,95%CI(0.57,1.03),P=0.08] and the incidence of stroke [OR =0.77,95%CI(0.48,1.24),P=0.28], without statistical significance. The incidence of major bleeding events [OR =1.54,95%CI(1.19,1.99),P=0.001] and minor bleeding events [OR =1.80,95% CI(1.40,2.32),P<0.000 01] in trial group were significantly higher than control group. CONCLUSIONS:Ticagrelor is comparable to clopidogrel in reduce the major adverse cardiovascular events,death from cardiovascular causes and stroke in ACS patients in East Asian ,but it can increase the risk of major and minor bleeding events.

2.
Chongqing Medicine ; (36): 439-441,445, 2015.
Artigo em Chinês | WPRIM | ID: wpr-600680

RESUMO

Objective To investigate the effect of high mobility group box‐1(HMGB1) on the migration of vascular smooth cells (VSMCs) and the role of TLR4‐dependent PI3K/Akt pathway in the process .Methods Primary VSMCs were isolated from the thoracic aorta of male SD rats and cultured in vitro .Control group ,TLR4 siRNA transfected group ,control siRNA transfected group and PI3k inhibitor (LY294002) intervention group were stimulated by HMGB1 (0 .1-1 000 .0 ng/mL) .Expression of TLR4 mRNA was detected by RT‐PCR ,protein expression of TLR4 ,Akt ,pAkt ,PI3K were detected by Western blot .Activity of the im‐munoprecipitated PI3K enzyme was assessed in a competitive ELISA .The migration and cell viability of every groups were ob‐served .Results HMGB1 (0 .1 -1 000 .0 ng/mL) stimulated VSMCs migration in a dose‐dependent manner and incubation of VSMCs with 100 ng/mL caused a rapid migration (P< 0 .05) .At the concentrations used ,HMGB1 did not cause any cytotoxic effects (P<0 .05) .Migration of VSMCs toward HMGB1 was significantly inhibited by silencing of TLR4 (P<0 .05) .Pretreated cells with TLR4 siRNA or the PI3K inhibitor LY294002 could markedly block PI3K/Akt pathway activation and VSMCs migration mediated by HMGB1 (both P<0 .05) .Conclusion HMGB1 stimulated VSMCs migration in a dose‐dependent manner and TLR4‐dependent PI3K/Akt signaling pathway played an important role in the migration of VSMCs mediated by HMGB1 .This research indicates that TLR4‐dependent TLR4/PI3K/Akt signaling pathway could be the target in the treatment of obstructive cardiovascu‐lar disease .

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA